DEA Proposes Waiver of Requirements for Distribution of Prescription Drug Products Containing List I Chemicals

Summary

The US Drug Enforcement Administration (DEA) is proposing to waive the registration requirement for individuals and companies that distribute prescription medications containing List I chemicals, as these products are already heavily regulated. This move aims to reduce the burden on distributors and manufacturers of these products, who would otherwise have to comply with DEA regulations that are not necessary for enforcing the law.